Search | Page 41 | Aplastic Anemia and MDS International Foundation

Search

Search results

  1. Clinical Trials Report for February 2015

    ... Study Coordinator Allogeneic Stem Cell Transplantation for Patients With Severe Aplastic Anemia For ... studied. hATG is made from horse blood and targets immune cells known as T-lymphocytes. Since T-lymphocytes are believed to be involved ...

    Page last updated 01/29/2015 - 10:10am.

  2. Combined Bone Marrow and Renal Transplantation for Hematologic Disorders With End Stage Renal Disease

    ... or other hematologic disorder for which hematopoietic stem cell transplantation would be ordinarily indicated and the reversal of ... a related donor Donor bone marrow (> 2 x 10e8 nucleated cells/kg of recipient body weight) is prepared for infusion according to the ...

    Clinical Trial last updated 06/06/2016 - 3:04pm.

  3. HSCT for Patients With Fanconi Anemia Using Risk-Adjusted Chemotherapy (RAFA)

    ... neupogen Biological: Peripheral blood stem cell The source of stem cells for all patients will be peripheral blood stem cells (PBSC) induced and ...

    Clinical Trial last updated 05/09/2016 - 3:19pm.

  4. SGI-110 With Donor Lymphocyte Infusion (DLI) for Acute Myelogenous Leukemia (AML) or Myelodysplastic Syndrome (MDS) Relapsing Post Allogeneic Stem Cell Transplantation (AlloSCT)

    ... study is to learn if giving donor lymphocyte cells and SGI-110 will help control AML and MDS. The safety of this treatment ... by vein over about 10-30 minutes. Other Names: DLI Stem cell transplantation AlloSCT ...

    Clinical Trial last updated 04/29/2016 - 12:20pm.

  5. Abatacept Reduced Intensity for Non-Malignant Diseases (Aba NMD)

    ... Purpose:  Allogeneic hematopoietic stem cell transplantation (HSCT) represents the only viable cure for children ... from graft versus host disease (GVHD), driven by donor T cells recognizing and reacting against disparate host antigens. This trial is ...

    Clinical Trial last updated 04/27/2016 - 2:40pm.

  6. 2013 Scholarships Awarded to Special Group of Young People

    ... brother and then try a bone marrow transplant using stem cells from his umbilical cord blood or try a clinical trial . They ...

    Page last updated 06/24/2015 - 10:22am.

  7. Allo HSCT Using RIC for Hematological Diseases

    ... regimen followed by a related or unrelated donor stem cell infusion. The primary objective is to evaluate rates of acute ... Mycophenolate Mofetil Biological: Peripheral Blood Stem Cells On day 0, patients will receive an allogeneic transplant using PBSC ...

    Clinical Trial last updated 05/02/2016 - 9:29am.

  8. Sapacitibine shows promise for high-risk MDS patients

    ... factors, to intensive therapy with allogeneic hematopoietic stem cell transplantation (HSCT). Treatment selection should be based on the ... can help decrease the growth of abnormal bone marrow cells and  restore gene expression.  Failure of the hypomethylating agents, ...

    Research Review last updated 05/02/2016 - 9:30am.

  9. Safety and Efficacy of Patient's Own AD-MSC and AD-HSC Transplantation in Patients With Severe Aplastic Anemia

    ... can be obtained in allogeneic blood or bone marrow stem cell transplantation using an human leukocyte antigen ( HLA ... (ATG) Procedure: Adipose derived mesenchymal stem cells ( AD-MSCs) Procedure: AD-MSC transdifferentiated HSCs (AD-HSCs) ...

    Clinical Trial last updated 04/08/2016 - 11:25pm.

  10. Overlap Syndromes: When PNH Appears with Aplastic Anemia or MDS

    ... who have significant increase in blasts (leukemia cells), a complex cytogenetic (chromosomal) abnormality or those with ... I use, those patients should generally be treated with a stem cell transplant , if they have a donor. To prepare them for the ...

    Interview last updated 05/14/2015 - 1:53pm.